Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Baudax Bio, Inc.
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
1
0
0
No Price
28.04.2026 20:00
Current Prices from Baudax Bio, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
BXRXQ
USD
28.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for Baudax Bio, Inc. Share
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
